Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community.

ABSTRACT:

Introduction

In the past decade, the atrial fibrillation (AF) landscape, including the treatment modalities, has drastically changed. This raises the question how AF prevalence and choices in antithrombotic therapy prescription have developed in the community over time.

Methods

Routine care data from the Julius General Practitioners' Network (JGPN) were used to calculate the yearly prevalence of AF and to quantify the percentage of all patients who were prescribed a platelet inhibitor, vitamin K antagonist (VKA), non-VKA oral anticoagulant (NOAC) or no antithrombotic medication. To explore whether certain patient characteristics are associated with selective prescription of oral anticoagulants (OAC), we applied logistic regression analyses.

Results

From 2008 through 2

SUBMITTER: Joosten LPT 

PROVIDER: S-EPMC9475006 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature